Aldeyra Therapeutics, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Aldeyra Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2023.
  • Aldeyra Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $18.2K, a 65.4% decline year-over-year.
  • Aldeyra Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$1.27M, a 204% decline from 2022.
  • Aldeyra Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1.22M, a 99.4% decline from 2021.
  • Aldeyra Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $194M, a 364% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1.27M -$2.49M -204% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $1.22M -$193M -99.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $194M +$153M +364% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $41.9M +$18.3M +77.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 $23.6M -$57M -70.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 $80.5M +$43.1M +115% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 $37.4M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.